No doubt, AI will transform cardiology as it is a specialty integrating vast amounts of data on patient history, symptoms, ECGs, laboratory values, and imaging of all sorts. So, what is left for the physician?

Read full article (Cardiovascular Research (2024) 00, 1–3)

Cardiogenic shock (CS) remains the primary cause of in-hospital death after acute coronary syndromes (ACS), with its plateauing mortality rates approaching 50%. However, its sex-specific performance remains unknown, and refined risk prediction strategies are warranted.

Read full article (European Heart Journal (2024) 00, 1–15)

Circulating proenkephalin (PENK) is a stable endogenous polypeptide with fast response to glomerular dysfunction and tubular damage. This study examined the predictive value of PENK for renal outcomes and mortality in patients with acute coronary syndrome (ACS).

Read full article (European Heart Journal (2024) 00, 1–17)

Obesity and type 2 diabetes (T2D) are major risk factors for cardiovascular (CV) diseases. Restoration of systemic SIRT1 may provide a novel therapeutic strategy to counteract toxic ceramide synthesis and mitigate CV complications of T2D.

Read full article (Cardiovascular Research (2024) 120, 1265–1278)
 

In 1946 and again in 1948, during the second and third Inter-American Congress of Cardiology, a club of friends amongst the European participants discussed the creation of the European Society of Cardiology (ESC). The ESC was officially founded on 2 September 1950... 

Read full article (European Heart Journal (2024) 00, 1–3)

This paper provides an overview of the current data revolution that has changed and will continue to change the face of clinical
medicine radically, if properly used, to the benefit of physicians and patients alike

Read full article (European Heart Journal - Cardiovascular Pharmacotherapy (2024) 00, 1–14)

In this paper, the authors aimed to assess the utilization, effectiveness, and safety of GPI in a large prospective multicentre cohort of contemporary ACS patients.

Read full article (European Heart Journal - Cardiovascular Pharmacotherapy (2024) 0 , 1–12)

The paradigm shift in the management of cardiogenic shock: moving from pure mechanical left ventricular unloading to neurohumoral and anti- inflammatory blockade with or without left ventricular mechanical assistance...

Read full article (European Heart Journal (2024) 00, 1–3)

A clinical consensus statement of the Heart Failure Association, the European Association of Cardiovascular Imaging, the ESC Working Group on Myocardial & Pericardial Diseases, and the European Heart Rhythm Association of the ESC

Read full article (European Heart Journal (2024) 00, 1–30)

Herz-Kreislauf-Erkrankungen sind die häufigste Todesursache in der Schweiz, entsprechend intensiv wird das Pumporgan erforscht. Sechs innovative Projekte.

1 — KI für Symptome bei Frauen Europaweite Analyse, Universität Zürich

Erfahren Sie mehr HIER (Horizonte, Dezember 2023)